国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2010年
3期
413-416
,共4页
刘致力%王英蓉%沙倩%聂庆珠
劉緻力%王英蓉%沙倩%聶慶珠
류치력%왕영용%사천%섭경주
视网膜%慢性高眼压%替普瑞酮%热休克蛋白70%视网膜神经节细胞
視網膜%慢性高眼壓%替普瑞酮%熱休剋蛋白70%視網膜神經節細胞
시망막%만성고안압%체보서동%열휴극단백70%시망막신경절세포
retina%chronic hypertention%geranylgeranylacetone%heat shock protein70%retinal ganglion cell
目的:研究慢性高眼压大鼠视网膜HSP70表达的变化及替普瑞酮的影响. 方法:Wistar大鼠70只随机分为3组:空白对照组10只;慢性高眼压模型组30只;慢性高眼压模型+GGA组30只.采用烧灼巩膜浅层静脉的方法制备大鼠慢性高眼压模型.模型成功后给予替普瑞酮800mg/(kg·d)每日灌胃.应用免疫组织化学方法观察应用及未应用替普瑞酮的慢性高眼压大鼠视网膜不同时点的差异及HSP70表达的变化.结果:平均眼压高于正常眼压40%的手术眼为造模成功.与正常对照组相比,慢性高眼压大鼠应用与未应用替普瑞酮者,视网膜均随着高眼压时间的延长逐渐出现形态学变化,于高眼压的21d和28d视网膜变薄,节细胞数量减少;在此过程中,HSP70表达增多.慢性高眼压大鼠视网膜应用替普瑞酮者与未应用提普瑞酮者相比,其形态学变化较小,而HSP70表达则明显增多,两者差异具有统计学意义(P<0.01).结论:替普瑞酮通过上调HSP70表达发挥对慢性高眼压视网膜的保护作用.
目的:研究慢性高眼壓大鼠視網膜HSP70錶達的變化及替普瑞酮的影響. 方法:Wistar大鼠70隻隨機分為3組:空白對照組10隻;慢性高眼壓模型組30隻;慢性高眼壓模型+GGA組30隻.採用燒灼鞏膜淺層靜脈的方法製備大鼠慢性高眼壓模型.模型成功後給予替普瑞酮800mg/(kg·d)每日灌胃.應用免疫組織化學方法觀察應用及未應用替普瑞酮的慢性高眼壓大鼠視網膜不同時點的差異及HSP70錶達的變化.結果:平均眼壓高于正常眼壓40%的手術眼為造模成功.與正常對照組相比,慢性高眼壓大鼠應用與未應用替普瑞酮者,視網膜均隨著高眼壓時間的延長逐漸齣現形態學變化,于高眼壓的21d和28d視網膜變薄,節細胞數量減少;在此過程中,HSP70錶達增多.慢性高眼壓大鼠視網膜應用替普瑞酮者與未應用提普瑞酮者相比,其形態學變化較小,而HSP70錶達則明顯增多,兩者差異具有統計學意義(P<0.01).結論:替普瑞酮通過上調HSP70錶達髮揮對慢性高眼壓視網膜的保護作用.
목적:연구만성고안압대서시망막HSP70표체적변화급체보서동적영향. 방법:Wistar대서70지수궤분위3조:공백대조조10지;만성고안압모형조30지;만성고안압모형+GGA조30지.채용소작공막천층정맥적방법제비대서만성고안압모형.모형성공후급여체보서동800mg/(kg·d)매일관위.응용면역조직화학방법관찰응용급미응용체보서동적만성고안압대서시망막불동시점적차이급HSP70표체적변화.결과:평균안압고우정상안압40%적수술안위조모성공.여정상대조조상비,만성고안압대서응용여미응용체보서동자,시망막균수착고안압시간적연장축점출현형태학변화,우고안압적21d화28d시망막변박,절세포수량감소;재차과정중,HSP70표체증다.만성고안압대서시망막응용체보서동자여미응용제보서동자상비,기형태학변화교소,이HSP70표체칙명현증다,량자차이구유통계학의의(P<0.01).결론:체보서동통과상조HSP70표체발휘대만성고안압시망막적보호작용.
AIM: To study the effects of geranylgeranylacetone(GGA) on the expression of heat shock protein70(HSP70) on retinal ganglion cells(RGC) in rats with chronic intraocular pressure(IOP) elevation.METHODS: Seventy Wistars were divided into blank control group(10 rats), chronic hypertension group(30 rats) and GGA group(30 rats). Chronic hypertension was created by cauterizing the superficial scleral veins. 800mg/(kg·d)GGA was given by oral daily after cauterization. Immunohistochemistry was used respectively to observe the changes of expression of HSP70 in the model rats and GGA interference rats at different time points during the course of chronic IOP elevation.RESULTS: The successful model was identified as the IOP over 40% of normal rats. The retinal thickness was significantly reduced in model group and model+ GGA group compared with normal rats from 21 days through 28 days after cauterization(P<0.05), and that of model rats was obviously decreased in comparison with model+ GGA rats(P<0.05). The number of ganglion cells was significantly decreased in model rats and model+ GGA rats compared with normal rats from 21 days and 28 days. The stronger expression intensity(IOD) value was seen for HSP70 in the model+ GGA rats by immunochemistry(P<0.01).CONCLUSION: Systemic administration of GGA protects retina from chronic IOP elevation by regulating the expression of HSP70.